PARTNERS

PARTNERS

Philogen has signed collaboration and/or licensing agreements with large pharmaceutical companies including:

• AbbVie
• Bayer
• Boehringer Ingelheim
• Celgene (a subsidiary of Bristol-Myers Squibb)
• Janssen Biotech, Inc. (a Johnson & Johnson company)
• MedImmune (a wholly owned subsidiary of AstraZeneca)
• Merck-Serono
• Novartis
• Pfizer
• Schering
• Servier

Our collaboration agreements with academic institutions include:

• ETH Zurich
• Scripps Research
• The German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ)
• University of Zurich
• Wyss Translational Center Zurich

A selection press releases about our collaborations are listed below:

• Philogen announces Option Exercise by Janssen
• Philogen announces collaboration with Celgene
• Philogen announces drug discovery collaboration with Johnson & Johnson Innovation
• Philogen announces collaboration with Novartis
• Philogen Announces Exercise of Options Within the License Agreement With AbbVie in the Field of Immuno-Inflammation
• Philogen and the Scripps Research Institute announce research collaboration in the field of DNA-Encoded Chemistry
• Project funded by POR CreO 2014-2020 for the expansion of a GMP production unit
• Project funded by POR CreO 2014-2020 for the realization of a Quality Control laboratory